共 50 条
- [4] BIOAVAILABILITY OF SUSTAINED-RELEASE AND NON SUSTAINED-RELEASE ISOSORBIDE-5-MONONITRATE [J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1989, 39-2 (10): : 1274 - 1276
- [5] SUSTAINED-RELEASE ISOSORBIDE MONONITRATE (50 MG) - OPTIMIZATION OF A ONCE-DAILY DOSAGE FORM FOR LONG-TERM TREATMENT OF ANGINA-PECTORIS [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1988, 61 (09): : E12 - E14
- [6] CAN TOLERANCE DEVELOPMENT WITH 5-ISOSORBIDE MONONITRATE BE AVOIDED WITH A ONCE-DAILY CONTROLLED-RELEASE FORMULATION [J]. ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 148 - 148
- [7] GALENICAL DEVELOPMENT OF A NEW SUSTAINED-RELEASE THEOPHYLLINE PELLET FORMULATION FOR ONCE-DAILY ADMINISTRATION [J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1988, 38-2 (8A): : 1203 - 1209
- [8] Correction to: Once-daily sustained-release matrix tablets of nicorandil: Formulation and in vitro evaluation [J]. AAPS PharmSciTech, 21
- [9] PHARMACOKINETICS OF ISOSORBIDE MONONITRATE IN A NEW SUSTAINED-RELEASE ORAL FORM IN COMPARISON WITH A CONVENTIONAL FORMULATION [J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1987, 37-2 (07): : 836 - 839